Business
MillerKnoll Updates Q3 2026 Earnings Guidance and Dividend Announcement
MillerKnoll (NASDAQ: MLKN) has revised its earnings guidance for the third quarter of 2026, projecting earnings per share (EPS) between $0.420 and $0.480. This update, announced on November 1, 2025, exceeds the consensus estimate of $0.410 per share. The company also provided revenue guidance of $923.0 million to $963.0 million, surpassing the consensus revenue estimate of $914.7 million.
Analysts’ Perspectives and Stock Performance
Recent evaluations by various analysts have influenced the perception of MillerKnoll’s stock. Zacks Research downgraded the company from a “strong-buy” to a “hold” rating earlier this week. In contrast, Wall Street Zen upgraded the stock from “hold” to “buy” just a few days prior. Currently, three analysts have assigned a “hold” rating, while one has issued a “sell” rating. According to data from MarketBeat, MillerKnoll’s stock holds an average rating of “Reduce.”
The company’s latest quarterly earnings were announced on December 17, 2025, where MillerKnoll reported an EPS of $0.43, exceeding the consensus estimate of $0.40 by $0.03. Despite this positive performance, the company reported a negative net margin of 0.41% along with a return on equity of 10.96%.
Dividend Declaration and Institutional Investments
In a move to return value to shareholders, MillerKnoll declared a quarterly dividend of $0.1875, which will be distributed on January 15, 2026. Shareholders on record as of November 29, 2025 will be eligible for this dividend, while the ex-dividend date is set for November 28, 2025. This dividend represents an annualized payout of $0.75, yielding approximately 4.3%. The company’s dividend payout ratio stands at a challenging -300.00%.
MillerKnoll has seen notable activity from institutional investors. The Royal Bank of Canada increased its stake by 39.4% in the first quarter, now holding 19,451 shares valued at approximately $373,000. Additionally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings by 2.0%, owning 40,480 shares worth around $775,000. Other significant movements include UBS Asset Management, which grew its position by 7.1%, and Jane Street Group LLC, which saw a dramatic 311.8% increase, now owning 414,275 shares valued at approximately $7.9 million.
Currently, institutional investors control 87.50% of MillerKnoll’s stock, reflecting strong investor interest and confidence in the company’s future prospects.
About MillerKnoll: MillerKnoll, Inc. specializes in researching, designing, manufacturing, and distributing interior furnishings on a global scale. The company operates through three segments: Americas Contract, International Contract & Specialty, and Global Retail, offering a diverse range of products including seating solutions, furniture systems, textiles, and furnishings for various sectors including residential, education, and healthcare.
With a proactive approach in adjusting its earnings guidance and announcing a dividend, MillerKnoll aims to maintain shareholder confidence and navigate the challenges ahead in the competitive market landscape.
-
Science2 months agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
-
Health2 months agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
-
Top Stories2 months agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
-
Entertainment2 months agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
-
Health2 months agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
-
Top Stories2 months agoFormer Mozilla CMO Launches AI-Driven Cannabis Cocktail Brand Fast
-
Entertainment2 months agoMother Fights to Reunite with Children After Kidnapping in New Drama
-
World2 months agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
-
World2 months agoIsrael Reopens Rafah Crossing After Hostage Remains Returned
-
Business2 months agoTyler Technologies Set to Reveal Q3 Earnings on October 22
-
Health2 months agoYouTube Launches New Mental Health Tools for Teen Users
-
Health2 months agoNorth Carolina’s Biotech Boom: Billions in New Investments
